No Influence of Nevirapine on Vitamin D Deficiency in HIV-Infected Patients

Abstract

AIDS Research and Human RetrovirusesVol. 25, No. 8 Letter to the EditorNo Influence of Nevirapine on Vitamin D Deficiency in HIV-Infected PatientsEmanuela Lattuada, Massimiliano Lanzafame, Giacomo Zoppini, Ercole Concia, and Sandro VentoEmanuela LattuadaInfectious Diseases Unit, Policlinico G.B. Rossi B.go Roma, Verona, Italy.Search for more papers by this author, Massimiliano LanzafameInfectious Diseases Unit, Policlinico G.B. Rossi B.go Roma, Verona, Italy.Search for more papers by this author, Giacomo ZoppiniEndocrinologic Unit, Department of Biomedical and Surgical Sciences, University of Verona, Ospedale Civile Maggiore B.go Trento, Verona, Italy.Search for more papers by this author, Ercole ConciaInfectious Diseases Unit, Policlinico G.B. Rossi B.go Roma, Verona, Italy.Search for more papers by this author, and Sandro VentoInfectious Diseases Unit, Annunziata Hospital, Cosenza, Italy.Search for more papers by this authorPublished Online:13 Aug 2009https://doi.org/10.1089/aid.2009.0063AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"No Influence of Nevirapine on Vitamin D Deficiency in HIV-Infected Patients." , 25(8), pp. 849–850FiguresReferencesRelatedDetailsCited byDetermination of optimal vitamin D 3 dosing regimens in HIV-infected paediatric patients using a population pharmacokinetic approach20 October 2014 | British Journal of Clinical Pharmacology, Vol. 78, No. 5Vitamin D and Calcium Abnormalities in the HIV-Infected PopulationEndocrinology and Metabolism Clinics of North America, Vol. 43, No. 3Change in Vitamin D Levels and Risk of Severe Vitamin D Deficiency over 48 Weeks among HIV-1-Infected, Treatment-Naive Adults Receiving Rilpivirine or Efavirenz in a Phase III Trial (Echo)1 February 2013 | Antiviral Therapy, Vol. 19, No. 2Vitamin D 3 supplementation scheme in HIV-infected patients based upon pharmacokinetic modelling of 25-hydroxycholecalciferol8 April 2013 | British Journal of Clinical Pharmacology, Vol. 75, No. 5A potential influence of vitamin D on HIV infection and bone disease in HIV-positive patientsHIV & AIDS Review, Vol. 12, No. 4Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patientsAIDS, Vol. 26, No. 3Prevalence of Hypovitaminosis D and Factors Associated With Vitamin D Deficiency and Morbidity Among HIV-Infected Patients Enrolled in a Large Italian CohortJAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 58, No. 2Vitamin D in HIV-Infected Patients7 June 2011 | Current HIV/AIDS Reports, Vol. 8, No. 3Do nevirapine and efavirenz affect vitamin D homeostasis similarly?AIDS, Vol. 25, No. 6Is lower serum 25-hydroxy vitamin D associated with efavirenz or the non-nucleoside reverse transcriptase inhibitor class?AIDS, Vol. 25, No. 6Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infectionAIDS, Vol. 25, No. 4The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations23 November 2010 | Current Infectious Disease Reports, Vol. 13, No. 1Low Vitamin D among HIV-Infected Adults: Prevalence of and Risk Factors for Low Vitamin D Levels in a Cohort of HIV-Infected Adults and Comparison to Prevalence among Adults in the US General Population9 January 2011 | Clinical Infectious Diseases, Vol. 52, No. 3 Volume 25Issue 8Aug 2009 InformationCopyright 2009, Mary Ann Liebert, Inc.To cite this article:Emanuela Lattuada, Massimiliano Lanzafame, Giacomo Zoppini, Ercole Concia, and Sandro Vento.No Influence of Nevirapine on Vitamin D Deficiency in HIV-Infected Patients.AIDS Research and Human Retroviruses.Aug 2009.849-850.http://doi.org/10.1089/aid.2009.0063Published in Volume: 25 Issue 8: August 13, 2009Online Ahead of Print:July 20, 2009PDF download